Aclarion Inc
NASDAQ:ACON 12:21:46 AM EDT
| Market Cap (Intraday) | 3.11M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.38 |
| 50-Day MA | $0.48 |
| 200-Day MA | $0.67 |
Aclarion Inc Stock, NASDAQ:ACON
8181 Arista Place, Suite 100, Broomfield, Colorado 80021
United States of America
Phone: +1.833.275.2266
Number of Employees: 7
Description
Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.